Role of endothelin ETB receptor in partial ablation-induced chronic renal failure in rats

European Journal of Pharmacology

Volumn 494, Issue 1, 2004, Pages 63-71

  Okada, Yuka ^a   Nakata, Mariko ^a   Izumoto, Hiromi ^a   Takasu, Mai ^a   Tazawa, Naoko ^a   Takaoka, Masanori ^a   Gariepy, Cheryl E ^b   Yanagisawa, Masashi ^c   Matsumura, Yasuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Chronic renal failure; Endothelin 1; ETB receptor; Hypertension; Renal mass reduction

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN B RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GENE DELETION; HEART; HISTOPATHOLOGY; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION; WILD TYPE; ANIMAL; CATHETER ABLATION; COMPARATIVE STUDY; GENETICS; METABOLISM; METHODOLOGY; PHYSIOLOGY; RAT STRAIN; SPRAGUE DAWLEY RAT;

ANIMALS; CATHETER ABLATION; KIDNEY FAILURE, CHRONIC; MALE; RATS; RATS, MUTANT STRAINS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN B;

EID: 2942541261     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.04.046     Document Type: Article

References (43)

1. Amann K., Rump L.C., Simonaviciene A., Oberhauser V., Wessels S., Orth S.R., Gross M-L., Koch A., Bielenberg G.W., Van Kats J.P., Ehmke H., Mall G., Ritz E. Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. J. Am. Soc. Nephrol. 11:2000;1469-1478
2. Anderson S., Rennke H.G., Brenner B.M. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J. Clin. Invest. 77:1986;1993-2000
3. Benigni A., Perico N., Gaspari F., Zoja C., Bellizzi L., Gabanelli M., Remuzzi G. Increased renal endothelin production in rats with reduced renal mass. Am. J. Physiol. 260:1991;F331-F339
4. Benigni A., Zoja C., Corna D., Orisio S., Longaretti L., Bertani T., Remuzzi G. A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int. 44:1993;440-444
5. Bidani A.K., Schwartz M.M., Lewis E.J. Renal autoregulation and vulnerability to hypertensive injury in remnant kidney. Am. J. Physiol. 252:1987;F1003-F1010
6. Brenner B.M., Meyer T.W., Hostetter T.H. Dietary protein intake and the progressive nature of kidney disease. The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation and intrinsic renal disease. N. Engl. J. Med. 307:1982;652-659
7. Brochu E., Lacasse M., Moreau S., Lebel C., Kingma M., Grose I., Larivière J.H. Endothelin ETA receptor blockade prevents the progression of renal failure and hypertension in uraemic rats. Nephrol. Dial. Transplant. 14:1999;1881-1888
8. Brooks D.P., DePalma P.D., Pullen M., Nambi P. Characterization of canine renal endothelin receptor subtypes and their function. J. Pharmacol. Exp. Ther. 268:1994;1091-1097
9. De Nucci G., Thomas R., D'Orlèans-Juste P., Antunes E., Walder C., Warner T.D., Vane J.R. The pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. U. S. A. 85:1988;9797-9800
10. Fukuda K., Yanagida T., Okuda S., Tamaki K., Ando T., Fujishima M. Role of endothelin as a mitogen in experimental glomerulonephritis in rats. Kidney Int. 49:1996;1320-1329
11. Fujihara C.K., De Nucci G., Zatz R. Chronic nitric oxide synthase inhibition aggravates glomerular injury in rats with subtotal nephrectomy. J. Am. Soc. Nephrol. 5:1995;1498-1507
12. A receptor in maintenance of deoxycorticosterone acetate-salt-induced hypertension. Br. J. Pharmacol. 114:1995;925-930
13. Garg U.C., Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83:1989;1774-1777
14. Gariepy C.E., Williams S.C., Cass D.T., Yanagisawa M. Null mutasion of endothelin receptor type B gene in spotting lethal rats causes aganglionic megacolon and white coat color. Proc. Natl. Acad. Sci. U. S. A. 93:1996;867-872
15. Gariepy C.E., Williams S.C., Richardson J.A., Hammer R.E., Yanagisawa M. Transgenic expression of the endothelin-B receptor prevents congenital intestinal aganglionosis in rat model of Hirschsprung disease. J. Clin. Invest. 102:1998;1092-1101
16. Gariepy C.E., Ohuchi T., Williams S.C., Richardson J.A., Yanagisawa M. Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J. Clin. Invest. 105:2000;925-933
17. Garvas H., Garvas I. Salt-induced hypertension: the interactive role of vasopressin and of the sympathetic nervous system. J. Hypertens. 7:1989;601-606
18. Goto K., Hama H., Kasuya Y. Molecular pharmacology and pathophysiological significance of endothelin. Jpn. J. Pharmacol. 72:1996;261-290
19. B receptor-mediated action on systemic and renal hemodynamics and urine formation in deoxycorticosterone acetate-salt-induced hypertensive rats. Biol. Pharm. Bull. 21:1998;800-804
20. Herrere-Acosta J. The role of systemic and glomerular hypertension in progressive glomerular injury. Kidney Int. 45(Suppl. 45):1994;S6-S10
21. Kagami S., Border W.A., Miller D.E., Noble N.A. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J. Clin. Invest. 93:1994;2431-2437
22. Klahr S., Schreiner G., Ichikawa I. The progression of renal disease. N. Engl. J. Med. 318:1988;1657-1666
23. Kohno M., Horio T., Yokokawa K., Yasunari K., Kurihara N., Takeda T. Endothelin modulates the mitogenic effect of PDGF on glomerular mesangial cells. Am. J. Physiol. 226:1994;F894-F900
24. Konishi F., Okada Y., Takaoka M., Gariepy C.E., Yanagisawa M., Matsumura Y. Role of endothelin ETB receptors in the renal hemodynamic and excretory responses to big endothelin-1. Eur. J. Pharmacol. 451:2002;177-184
25. Larivière R., Lebel M., Kingma I., Grose J.H., Boucher D. Effects of losartan and captopril on endothelin-1 production in blood vessels and glomeruli of rats with reduced renal mass. Am. J. Hypertens. 11:1998;989-997
26. Lebel M., Grose J.H., Kingma I., Langlois S. Plasma endothelin levels and blood pressure in hemodialysis and in CAPD patients: effect of subcutaneous erythropoietin replacement therapy. Clin. Exp. Hypertens. 16:1994;565-575
27. Lewis E.J., Hunsicker L.G., Bain R.P., Rohde R.D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 329:1993;1456-1462
28. Maschio G., Alberti D., Janin G., Locatelli F., Mann J.F.E., Motolese M., Ponticelli C., Ritz E., Zucchelli P. The angiotensin-converting-enzyme inhibition in progressive renal insufficiency study group: effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N. Engl. J. Med. 334:1996;939-945
29. Matsumura Y., Ikegawa R., Takaoka M., Morimoto S. Conversion of porcine big endothelin to endothelin by an extract from the porcine aortic endothelial cells. Biochem. Biophys. Res. Commun. 167:1990;203-210
30. Matsumura Y., Kuro T., Kobayashi Y., Konishi F., Takaoka M., Wessale J.L., Opgenorth T.J., Gariepy C.E., Yanagisawa M. Exaggerated vascular and renal pathology in endothelin-B receptor-deficient rats with deoxycorticosterone acetate-salt hypertension. Circulation. 102:2000;2765-2773
31. Matsuo G., Matsumura Y., Tadano K., Morimoto S. Effects of sarafotoxin S6c on antidiuresis and norepinephrine overflow induced by stimulation of renal nerves in anesthetized dogs. J. Pharmacol. Exp. Ther. 280:1997;905-910
32. Mattana J., Singhal R.P. L-Arginine supplementation antagonizes the effects of angiotensin II and endothelin-1 on mesangial cell proliferation. Cell. Physiol. Biochem. 5:1995;176-192
33. Nabokov A., Amann K., Wagner J., Gehlen F., Munter K., Ritz E. Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablation. Nephrol. Dial. Transplant. 11:1996;514-520
34. Nabokov A., Amann K., Wessels S., Munter K., Wagner J., Ritz E. Endothelin receptor antagonists influence cardiovascular morphology in uremic rats. Kidney Int. 55:1999;512-519
35. Nagayama T., Kuwakubo F., Matsumoto T., Fukushima Y., Yoshida M., Suzuki-Kusaba M., Hisa H., Matsumura Y., Kimura T., Satoh S. Role of endogenous endothelins in catecholamine secretion in the rat adrenal gland. Eur. J. Pharmacol. 406:2000;69-74
36. A receptor antagonist BQ123 antagonizes endothelin-1-mediated mitogenesis. Eur. J. Pharmacol. 225:1992;347-350
37. Orisio S., Benigni A., Bruzzi I., Corna D., Perico N., Zoja C., Benatti L., Remuzzi G. Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int. 43:1993;354-358
38. 1 receptors on glomerular injury in Dahl salt-sensitive rats. Am. J. Physiol. 274:1998;R1797-R1806
39. A receptor blockade prevents hypertension associated with exogenous endothelin-1 but not renal mass reduction in the rat. J. Am. Soc. Nephrol. 8:1997;1054-1060
40. Pollock D.M., Divish B.J., Polakowski J.S., Opgenorth T.J. Angiotensin II receptor blockade improves renal function in rats with reduced renal mass. J. Pharmacol. Exp. Ther. 267:1993;657-663
41. Reyes A.A., Purkerson M.L., Karl I., Klahr S. Dietary supplementation with L-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy. Am. J. Kidney Dis. 20:1992;168-176
42. Shimizu T., Hata S., Kuroda T., Mihara S., Fujimoto M. Different roles of two types of endothelin receptors in partial ablation-induced chronic renal failure in rats. Eur. J. Pharmacol. 381:1999;39-49
43. Takayanagi R., Kitazumi K., Takasaki C., Ohnaka K., Aimoto S., Tasaka K., Ohashi M., Nawata H. Presence of non-selective type of endothelin receptor on vascular endothelium and its linkage to vasodilation. FEBS Lett. 282:1991;103-106